Literature DB >> 9489928

The D3 dopamine receptor in cellular and organismal function.

R A Shafer1, B Levant.   

Abstract

The D3 dopamine receptor is a member of the family of D2-like dopamine receptors. Since the cloning and identification of the D3 receptor in 1990, considerable progress has been made towards understanding the function of this novel site. Although some avenues of investigation have yielded more definitive results than others, studies to date indicate the D3 receptor is localized preferentially in limbic brain areas and affects locomotion and perhaps reinforcement and reward. A subpopulation of the receptors appear to be autoreceptors which modulate dopamine synthesis, release, and neuronal activity. These observations have led to the hypothesis that the D3 receptor may be an appropriate target in the treatment of neuropsychiatric disorders such as schizophrenia and drug addiction. The role of D3 sites in disease, however, remains to be established. Genetic association of D3 receptor polymorphisms with neuropsychiatric disorders have been proposed. Alterations in expression of D3 sites may occur in some diseases. Although the study of this receptor is clearly in the early stages, these findings lay the foundation for future investigation. In this review, dopamine D3 receptor brain localization, cellular signaling mechanisms, and associated behavior will be discussed. The potential role of the D3 site in neuropsychiatric disorders and as a therapeutic target is also addressed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489928     DOI: 10.1007/s002130050479

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

Review 1.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

2.  Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.

Authors:  Ying Qu; Neal R Swerdlow; Martin Weber; David Stouffer; Loren H Parsons
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

Review 3.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

4.  Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats.

Authors:  Su-Min Li; Gregory T Collins; Noel M Paul; Peter Grundt; Amy H Newman; Ming Xu; David K Grandy; James H Woods; Jonathan L Katz
Journal:  Behav Pharmacol       Date:  2010-05       Impact factor: 2.293

5.  Salviae miltiorrhizae radix inhibits superoxide generation by activated rat microglias and mimics the action of amphetamine on in vitro rat striatal dopamine release.

Authors:  Byung-Soo Koo; Tae-Sig Kwon; Cheorl-Ho Kim
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

6.  Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.

Authors:  C Betancur; I Lépée-Lorgeoux; M Cazillis; D Accili; S Fuchs; W Rostène
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

7.  Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors.

Authors:  Francoise Rouge-Pont; Alessandro Usiello; Marianne Benoit-Marand; Francois Gonon; Pier Vincenzo Piazza; Emiliana Borrelli
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

8.  Salviae Miltiorrhizae BGE Radix increases rat striatal K(+)-stimulated dopamine release and activates the dopamine release with protection against hydrogen peroxide-induced injury in rat pheochromocytoma PC12 cells.

Authors:  Tae-Wook Chung; Byung-Soo Koo; Kyeong-Oh Kim; Hee-Sang Jeong; Min-Gon Kim; Kang-Hung Chung; In-Seon Lee; Cheorl-Ho Kim
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

9.  Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15.

Authors:  Béla Kiss; István Laszlovszky; Attila Horváth; Zsolt Némethy; Eva Schmidt; Gyula Bugovics; Károly Fazekas; István Gyertyán; Eva Agai-Csongor; György Domány; Zsolt Szombathelyi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-13       Impact factor: 3.000

10.  The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity.

Authors:  Panayotis K Thanos; Michael Michaelides; Christopher W Ho; Gene-Jack Wang; Amy H Newman; Christian A Heidbreder; Charles R Ashby; Eliot L Gardner; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2008-02-08       Impact factor: 3.533

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.